Skipping Koning CT Breast Imaging Procedures Increases Risk of Breast Cancer-related Mortality Rates!

Breast cancer is a pervasive breast disease that has impacted millions of women worldwide, leading to significant morbidity and mortality. 

While progress has been made in the field of breast cancer treatment, early detection remains one of the most effective strategies for improving patient outcomes.

In recent years, there has been growing interest in the use of KoningCT breast imaging procedures to screen for breast cancer. Evidence shows that skipping these procedures could increase the risk of breast cancer death.

Traditionally, mammography has been the primary screening method for breast cancer!

However, concerns regarding the accuracy of mammography have led to the development of alternative screening modalities, including Koning CT breast imaging procedures. These procedures use cone-beam computed tomography technology to image the breast and detect abnormalities that may indicate the presence of breast cancer.

Research shows that failing to undergo breast cancer screening, including Koning CT breast imaging procedures, can lead to delayed diagnoses and increased mortality rates.

 A study published in the Journal of the National Cancer Institute found that women who skipped regular mammograms had a higher risk of dying from breast cancer. 

Similarly, a study published in the Journal of Medical Screening found that women who skipped mammograms experienced a 60% higher risk of breast cancer mortality compared to those who underwent regular screening.

USPSTF Recommendations!

The United States Preventive Services Task Force recommends that women at average risk for breast cancer undergo screening mammograms every two years, starting at age 40 and continuing until age 74.

 This recommendation is based on extensive research into the efficacy and safety of mammography. While mammography has its limitations, it remains an important tool for detecting breast cancer.

Koning CT breast imaging procedures offer several advantages over traditional mammography!

These procedures do not require breast compression, reducing the discomfort associated with mammography. 

Additionally, Koning CT scans each breast in just 7 seconds, compared to the longer time needed for mammography. This means that patients can complete their breast cancer screening more quickly, reducing the burden on both patients and healthcare systems.

The Koning CT detects cancer at stages 0 to stage 1. Certain breast lesions, refer as Atypical hyperplasia ( non-cancerous condition) or lobular carcinoma in situ (LCIS), maybe less than 2mm lesions and 200-micron calcifications, and can't overlap tissues or breast lesions - anywhere they hide.

Decrease False-positive biopsy recall with Koning Breast CT:

Breast cancer screening is a crucial aspect of maintaining optimal breast health. However, traditional mammography procedures are often uncomfortable and frequently cause anxiety for women. 

Moreover, mammography can also lead to false-positive recalls (16.3% to 9.6% at the next mammography), resulting in unnecessary procedures and discomfort for patients. 

The chance of receiving a false-positive biopsy recommendation was 2.5% initially and 1.0% during subsequent examinations. The availability of comparison mammograms reduced the likelihood of a false-positive recall by half. If a woman starts screening at the age of 40, the total likelihood of her receiving at least one false-positive recall after 10 years was 61.3% with annual screening and 41.6% with biennial screening.

False-positive recall probability tends to decrease at subsequent mammography screenings:

Still, it remains a prevalent issue in breast cancer screening procedures. False-positive results cause stress, anxiety, pain, and discomfort to women who may undergo unnecessary procedures. However, the availability of comparison mammograms can halve the odds of a false-positive recall, showing that further research is needed to develop new breast imaging technology.

Fortunately, recent research indicates that Koning Breast CT can decrease the likelihood of false-positive biopsy recalls, significantly mitigating patient discomfort and increasing survival rates.

Current Breast Imaging Koning Breast CT Advanced Medical Technology!

Koning Breast CT is one such advancement in breast imaging technology. KBCT produces high-contrast 3D images of the breast with exceptional spatial resolution. 

Compared to mammography screenings, KBCT does not require painful breast compression, reducing the discomfort associated with traditional breast cancer screening methods.

Furthermore, KBCT screening is completed in just 10 seconds with dosage levels similar to diagnostic mammograms.

 

360-degree Scanning Angle Can't Overlap Tissues!   

The technology used in Koning Breast CT has a 360-degree scanning angle that can’t overlap tissues, making it ideal for women who may be more difficult to screen using traditional mammography. 

In fact, with Koning Breast CT, clinicians can visualise and assess breast tissue size more accurately, mitigating patient discomfort and increasing survival rates. 

Future versions of the technology are expected to optimise early breast disorder detection, diagnosis, intervention, and treatment.

Where You Can Find Koning Breast CT Medical Equipment?

Our Koning Breast CT medical equipment is available globally, with locations available across Europe, Asia, Africa, the Caribbean and the USA. 

Euronoxx Medical Group, a reputable Medical Equipment healthcare supplier, provides the best quality Medical Devices and high-quality laboratory equipment. 

Now we proactively introducing our latest medical equipment, the Koning Breast CT technology. It provides a simplified breast screening workflow, reducing false screening recalls, saving screening time, and improving medical efficacy, giving healthcare specialists and patients an improved way of breast imaging.

 

Conclusion:

Several research has shown that Koning Breast CT can decrease the likelihood of false-positive biopsy recalls, mitigating patient discomfort while improving cancer survival rates. 

As advanced medical technology continues to evolve, breast CT imaging will become more accurate, efficient, and patient-friendly. 

In the meantime, women should discuss their breast cancer screening options with their healthcare providers and make informed decisions about the best screening method for their individual needs and preferences. 

Contact Euronoxx Medical Group today to learn more about Koning Breast CT Patient Monitoring Laboratory Equipment installation in your medical institutes, NHS, or set up the Koning Breast CT Patient Monitoring lab equipment donations into your charitable organisations and how it can make a difference in your healthcare.